Su‐jin Rhee
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
- Health Information Management top 10%
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 5
- Pharmacogenetics and Drug Metabolism 5
-
- Metabolism, Diabetes, and Cancer 3
- Co-authors
- Kyung‐Sang Yu (23 shared papers)SeungHwan Lee (13 shared papers)In‐Jin Jang (13 shared papers)Joo‐Youn Cho (9 shared papers)Sungzoon Cho (2 shared papers)Yun Kim (8 shared papers)Seokho Kang (2 shared papers)Jae‐Yong Chung (4 shared papers)
- Journals
- Drug Design Development and Therapy (5 papers)Scientific Reports (2 papers)Pharmaceutics (1 paper)Expert Opinion on Drug Safety (1 paper)BioMed Research International (1 paper)
- Partner nations
- South KoreaPuerto RicoUnited States
In The Last Decade
Su‐jin Rhee
41 papers receiving 397 citations
Peers
Comparison fields: 5 of 111
- Pharmacology 41
- Health Information Management 18
- Urology 19
- Pharmacology 50
- Endocrinology, Diabetes and Metabolism 45
Countries citing papers authored by Su‐jin Rhee
This map shows the geographic impact of Su‐jin Rhee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su‐jin Rhee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su‐jin Rhee more than expected).
Fields of papers citing papers by Su‐jin Rhee
This network shows the impact of papers produced by Su‐jin Rhee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su‐jin Rhee. The network helps show where Su‐jin Rhee may publish in the future.
Co-authors
The 25 scholars most cited alongside Su‐jin Rhee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 41 | |
| 2 | 2017 | 30 | |
| 3 | 2017 | 21 | |
| 4 | 2018 | 21 | |
| 5 | 2014 | 21 | |
| 6 | 2024 | 20 | |
| 7 | 2021 | 19 | |
| 8 | 2017 | 17 | |
| 9 | 2019 | 17 | |
| 10 | 2019 | 16 | |
| 11 | 2016 | 15 | |
| 12 | 2022 | 13 | |
| 13 | 2022 | 12 | |
| 14 | 2021 | 12 | |
| 15 | 2018 | 11 | |
| 16 | 2019 | 11 | |
| 17 | 2016 | 10 | |
| 18 | 2016 | 10 | |
| 19 | 2020 | 7 | |
| 20 | 2017 | 7 |
About Su‐jin Rhee
Su‐jin Rhee is a scholar working on Pharmacology, Molecular Biology, Oncology, Epidemiology and Pharmacology, having authored 42 papers that have together received 404 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Pharmacogenetics and Drug Metabolism (5 papers), Diabetes Treatment and Management (4 papers), Renal Transplantation Outcomes and Treatments (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). The work is most often cited by research in Pharmacology (41 citations), Health Information Management (18 citations), Urology (19 citations), Pharmacology (50 citations) and Endocrinology, Diabetes and Metabolism (45 citations). Su‐jin Rhee has collaborated with scholars based in South Korea, Puerto Rico and United States. Frequent co-authors include Kyung‐Sang Yu, SeungHwan Lee, In‐Jin Jang, Joo‐Youn Cho, Sungzoon Cho, Yun Kim, Seokho Kang, Jae‐Yong Chung, SoJeong Yi and Pilsung Kang. Their work appears in journals such as Drug Design Development and Therapy, Scientific Reports, Pharmaceutics, Expert Opinion on Drug Safety and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.